Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

$24.99

Statement of Comprehensive Income

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Moderna Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income (loss)
Unrealized gains (losses) on available-for-sale debt securities
Net realized (gains) losses on available-for-sale securities reclassified to net income (loss)
Net increase (decrease) from available-for-sale debt securities
Unrealized gains (losses) on derivative instruments
Net realized (gains) losses on derivative instruments reclassified to net income (loss)
Net increase (decrease) from derivatives designated as hedging instruments
Pension and postretirement obligation adjustments
Pension and postretirement benefit plans
Other comprehensive income (loss), net of tax
Comprehensive income (loss)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Moderna Inc. net income (loss) decreased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income (loss) Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Moderna Inc. comprehensive income (loss) decreased from 2021 to 2022 and from 2022 to 2023.